IMIST


Tachykinins / (notice n° 18763)

000 -LEADER
fixed length control field 01509nam a2200253 4500
001 - CONTROL NUMBER
control field UNI0000318
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20161124110503.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 120418s2004 XX eng
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 3540206906 (hardcover)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783540206903 (hardcover)
040 ## - CATALOGING SOURCE
Modifying agency IMIST
Description conventions AFNOR
040 ## - CATALOGING SOURCE
Original cataloging agency DCLC
041 1# - LANGUAGE CODE
Language code of text/sound track or separate title eng
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 615.1
245 #0 - TITLE STATEMENT
Title Tachykinins /
Statement of responsibility, etc Peter Holzer.
250 ## - EDITION STATEMENT
Edition statement 1st ed.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc [Berlin]
Name of publisher, distributor, etc Springer
Date of publication, distribution, etc 2004.
300 ## - PHYSICAL DESCRIPTION
Extent 569 p. ;
Dimensions 24 cm.
490 1# - SERIES STATEMENT
Series statement Handbook of experimental pharmacology.
500 ## - GENERAL NOTE
General note The tachykinins represent one of the most thoroughly investigated family of neuropeptides, whose members and receptors have been characterized at the genetic and molecular level and whose pharmacology has now been advanced to the first clinical application. These exciting accomplishments and prospects are reviewed and discussed in this volume in an authoritative manner. Particular emphasis is laid on the development of selective non-peptide antagonists for all 3 tachykinin receptors and their potential as novel drugs in a variety of diseases. The approval of the first tachykinin receptor antagonist as an antiemetic drug is particularly highlighted, and the utility of tachykinin receptor antagonists in affective disorders, chronic obstructive airway disease and irritable bowel syndrome, to name a few indications, is extensively considered.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Tachykinins
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Tachykinins--Physiological effect
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Holzer,, Peter.
Exemplaires
Withdrawn status Lost status Damaged status Not for loan Permanent Location Current Location Date acquired Inventory number Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
        La bibliothèque des Sciences Médicales et Pharmaceutiques La bibliothèque des Sciences Médicales et Pharmaceutiques   10870   615.1 HOL 0000000016134 11/24/2016 11/24/2016 Livre
© Tous droits résérvés IMIST/CNRST
Angle Av. Allal Al Fassi et Av. des FAR, Hay Ryad, BP 8027, 10102 Rabat, Maroc
Tél:(+212) 05 37.56.98.00
CNRST / IMIST

Propulsé par Koha